Lee Chan Henry 4

What Happened Lee Chan Henry, Senior Vice President and General Counsel of BeOne Medicines Ltd. (ONC), sold a total of 871 American Depositary Shares (ADSs) on June 8, 2026, for aggregate proceeds of $235,539. The sales were reported as: 711 ADSs at a weighted average price of $270.24 (≈ $192,138) and 160 ADSs at a weighted average price of $271.26 (≈ $43,401). Each ADS represents 13 ordinary shares, so the 871 ADSs correspond to 11,323 ordinary shares. These were sales (not purchases) and were effected to satisfy tax withholding obligations related to RSU vesting.

Key Details

• Transaction date: June 8, 2026; Form 4 filed June 10, 2026 (timely filing).
• Lots and prices: 711 ADSs @ $270.24 (weighted avg; underlying trades ranged $269.90–$270.86) and 160 ADSs @ $271.26 (weighted avg; underlying trades ranged $271.00–$271.43).
• Total proceeds: $235,539.
• Reason: Sale pursuant to mandatory tax withholding on the vesting of a restricted share unit (RSU) award (footnote). RSUs vest 1/4 each year on anniversaries of June 5, 2024, subject to continued service; certain change-in-control terminations can accelerate vesting.
• ADS ratio: 1 ADS = 13 ordinary shares (footnote).
• Post-transaction holdings: Not specified in the provided data.
• Footnote disclosure: Reporter can provide detailed per-trade price/quantity info to the SEC or security holders upon request.

Context This was a tax-withholding sale tied to RSU vesting (a common, routine reason insiders sell shares) rather than an open-market sale for investment purposes. Such withholding sales typically do not signal the insider’s view on the company’s outlook.